Transient receptor potential ankyrin 1 channel localized to non-neuronal airway cells promotes non-neurogenic inflammation

PLoS One. 2012;7(8):e42454. doi: 10.1371/journal.pone.0042454. Epub 2012 Aug 14.

Abstract

Background: The transient receptor potential ankyrin 1 (TRPA1) channel, localized to airway sensory nerves, has been proposed to mediate airway inflammation evoked by allergen and cigarette smoke (CS) in rodents, via a neurogenic mechanism. However the limited clinical evidence for the role of neurogenic inflammation in asthma or chronic obstructive pulmonary disease raises an alternative possibility that airway inflammation is promoted by non-neuronal TRPA1.

Methodology/principal findings: By using Real-Time PCR and calcium imaging, we found that cultured human airway cells, including fibroblasts, epithelial and smooth muscle cells express functional TRPA1 channels. By using immunohistochemistry, TRPA1 staining was observed in airway epithelial and smooth muscle cells in sections taken from human airways and lung, and from airways and lung of wild-type, but not TRPA1-deficient mice. In cultured human airway epithelial and smooth muscle cells and fibroblasts, acrolein and CS extract evoked IL-8 release, a response selectively reduced by TRPA1 antagonists. Capsaicin, agonist of the transient receptor potential vanilloid 1 (TRPV1), a channel co-expressed with TRPA1 by airway sensory nerves, and acrolein or CS (TRPA1 agonists), or the neuropeptide substance P (SP), which is released from sensory nerve terminals by capsaicin, acrolein or CS), produced neurogenic inflammation in mouse airways. However, only acrolein and CS, but not capsaicin or SP, released the keratinocyte chemoattractant (CXCL-1/KC, IL-8 analogue) in bronchoalveolar lavage (BAL) fluid of wild-type mice. This effect of TRPA1 agonists was attenuated by TRPA1 antagonism or in TRPA1-deficient mice, but not by pharmacological ablation of sensory nerves.

Conclusions: Our results demonstrate that, although either TRPV1 or TRPA1 activation causes airway neurogenic inflammation, solely TRPA1 activation orchestrates an additional inflammatory response which is not neurogenic. This finding suggests that non-neuronal TRPA1 in the airways is functional and potentially capable of contributing to inflammatory airway diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bronchoalveolar Lavage Fluid
  • Calcium Channels / biosynthesis*
  • Calcium Channels / physiology*
  • Epithelial Cells / metabolism
  • Fibroblasts / metabolism
  • Gene Expression Regulation*
  • Humans
  • Immunohistochemistry / methods
  • Inflammation
  • Interleukin-8 / biosynthesis
  • Interleukin-8 / metabolism
  • Mice
  • Mice, Transgenic
  • Muscle, Smooth / metabolism
  • Nerve Tissue Proteins / biosynthesis*
  • Nerve Tissue Proteins / physiology*
  • Respiratory System / pathology*
  • Smoking
  • TRPA1 Cation Channel
  • TRPV Cation Channels / biosynthesis
  • Transient Receptor Potential Channels / biosynthesis*
  • Transient Receptor Potential Channels / physiology*

Substances

  • Calcium Channels
  • Interleukin-8
  • Nerve Tissue Proteins
  • TRPA1 Cation Channel
  • TRPA1 protein, human
  • TRPV Cation Channels
  • TRPV1 protein, human
  • Transient Receptor Potential Channels
  • Trpa1 protein, mouse

Grants and funding

This work was supported by grants from Regione Toscana: “Regional Health Research Program 2009” and “FABER – POR CREO, FESR 2007-2013 1.1.C.” and the Italian Institute of Technology, “Project SEED”, and Ente Cassa di Risparmio di Firenze. The work was also funded by AstraZenca; this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.